ARTICLE
|
doi:10.20944/preprints202307.1905.v1
Subject:
Medicine And Pharmacology,
Pharmacology And Toxicology
Keywords:
Colorectal cancer; pharmacovigilance; BRAF inhibitors; regorafenib; encorafenib; adverse drug reactions; renal disorders
Online: 28 July 2023 (02:34:59 CEST)